Johnson & Johnson’s 4Q profit jumps 19 pct on higher prescription drug sales, tax benefit

NEW BRUNSWICK, N.J. – Johnson & Johnson says fourth-quarter profit jumped 19 per cent, as prescription drug sales climbed sharply and the health care giant enjoyed a big tax benefit.

The maker of baby shampoo, biological drugs and medical devices says fourth-quarter net income was $3.52 billion, or $1.23 per share, up from $2.57 billion, or 91 cents per share, a year earlier.

Excluding one-time items, net income was $3.56 billion, or $1.24 per share.

Revenue totalled $18.36 billion, up 4.5 per cent from $17.56 billion a year ago.

Analysts surveyed by FactSet were expecting, on average, earnings per share of $1.20 and revenue of $17.94 billion.

The company, based in New Brunswick, N.J., says it expects earnings per share of $5.75 to $5.85 in 2014. That’s up from $4.81 per share earned in 2013.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.